Literature DB >> 23225384

Upregulation of chemokines and their receptors in Duchenne muscular dystrophy: potential for attenuation of myofiber necrosis.

Boel De Paepe1, Kim K Creus, Jean-Jacques Martin, Jan L De Bleecker.   

Abstract

INTRODUCTION: In Duchenne muscular dystrophy (DMD), the infiltration of skeletal muscle by immune cells aggravates disease, yet the precise mechanisms behind these inflammatory responses remain poorly understood. Chemotactic cytokines, or chemokines, are considered essential recruiters of inflammatory cells to the tissues.
METHODS: We assayed chemokine and chemokine receptor expression in DMD muscle biopsies (n = 9, average age 7 years) using immunohistochemistry, immunofluorescence, and in situ hybridization.
RESULTS: CXCL1, CXCL2, CXCL3, CXCL8, and CXCL11, absent from normal muscle fibers, were induced in DMD myofibers. CXCL11, CXCL12, and the ligand-receptor couple CCL2-CCR2 were upregulated on the blood vessel endothelium of DMD patients. CD68(+) macrophages expressed high levels of CXCL8, CCL2, and CCL5.
CONCLUSIONS: Our data suggest a possible beneficial role for CXCR1/2/4 ligands in managing muscle fiber damage control and tissue regeneration. Upregulation of endothelial chemokine receptors and CXCL8, CCL2, and CCL5 expression by cytotoxic macrophages may regulate myofiber necrosis.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23225384     DOI: 10.1002/mus.23481

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  28 in total

1.  METTL21C is a potential pleiotropic gene for osteoporosis and sarcopenia acting through the modulation of the NF-κB signaling pathway.

Authors:  Jian Huang; Yi-Hsiang Hsu; Maxrco Brotto; David Karasik; Chenglin Mo; Eduardo Abreu; Douglas P Kiel; Lynda F Bonewald
Journal:  J Bone Miner Res       Date:  2014-07       Impact factor: 6.741

2.  Multiplex Screen of Serum Biomarkers in Facioscapulohumeral Muscular Dystrophy.

Authors:  Jeffrey Statland; Colleen M Donlin-Smith; Stephen J Tapscott; Silvere van der Maarel; Rabi Tawil
Journal:  J Neuromuscul Dis       Date:  2014

Review 3.  Muscle cell-derived cytokines in skeletal muscle regeneration.

Authors:  Rachel J Waldemer-Streyer; Dongwook Kim; Jie Chen
Journal:  FEBS J       Date:  2022-01-24       Impact factor: 5.622

Review 4.  Ongoing therapeutic trials and outcome measures for Duchenne muscular dystrophy.

Authors:  Alessandra Govoni; Francesca Magri; Simona Brajkovic; Chiara Zanetta; Irene Faravelli; Stefania Corti; Nereo Bresolin; Giacomo P Comi
Journal:  Cell Mol Life Sci       Date:  2013-06-18       Impact factor: 9.261

Review 5.  Immune-mediated pathology in Duchenne muscular dystrophy.

Authors:  Amy S Rosenberg; Montserrat Puig; Kanneboyina Nagaraju; Eric P Hoffman; S Armando Villalta; V Ashutosh Rao; Lalage M Wakefield; Janet Woodcock
Journal:  Sci Transl Med       Date:  2015-08-05       Impact factor: 17.956

Review 6.  The danger model approach to the pathogenesis of the rheumatic diseases.

Authors:  César Pacheco-Tena; Susana Aideé González-Chávez
Journal:  J Immunol Res       Date:  2015-04-20       Impact factor: 4.818

7.  Electrical stimuli are anti-apoptotic in skeletal muscle via extracellular ATP. Alteration of this signal in Mdx mice is a likely cause of dystrophy.

Authors:  Denisse Valladares; Gonzalo Almarza; Ariel Contreras; Mario Pavez; Sonja Buvinic; Enrique Jaimovich; Mariana Casas
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

Review 8.  Cytokines and chemokines as regulators of skeletal muscle inflammation: presenting the case of Duchenne muscular dystrophy.

Authors:  Boel De Paepe; Jan L De Bleecker
Journal:  Mediators Inflamm       Date:  2013-11-05       Impact factor: 4.711

9.  Palmitoleic acid prevents palmitic acid-induced macrophage activation and consequent p38 MAPK-mediated skeletal muscle insulin resistance.

Authors:  Nicola A Talbot; Caroline P Wheeler-Jones; Mark E Cleasby
Journal:  Mol Cell Endocrinol       Date:  2014-06-26       Impact factor: 4.102

10.  Tissue-Specific Gene Repositioning by Muscle Nuclear Membrane Proteins Enhances Repression of Critical Developmental Genes during Myogenesis.

Authors:  Michael I Robson; Jose I de Las Heras; Rafal Czapiewski; Phú Lê Thành; Daniel G Booth; David A Kelly; Shaun Webb; Alastair R W Kerr; Eric C Schirmer
Journal:  Mol Cell       Date:  2016-06-02       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.